Cargando…
The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases
Emerging and relapsing infectious diseases pose a huge health threat to human health and a new challenge to global public health. Rapid, sensitive and simple diagnostic tools are keys to successful management of infectious patients and containment of disease transmission. In recent years, internatio...
Autores principales: | Lou, Juan, Wang, Bin, Li, Junwei, Ni, Peng, Jin, Yuefei, Chen, Shuaiyin, Xi, Yuanlin, Zhang, Rongguang, Duan, Guangcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297709/ https://www.ncbi.nlm.nih.gov/pubmed/35857175 http://dx.doi.org/10.1007/s11033-022-07752-z |
Ejemplares similares
-
Application of CRISPR/Cas Systems in the Nucleic Acid Detection of Infectious Diseases
por: Li, Junwei, et al.
Publicado: (2022) -
CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
por: Ding, Ronghua, et al.
Publicado: (2021) -
Involvement of the renin-angiotensin system in the progression of severe hand-foot-and-mouth disease
por: Zhang, Chao, et al.
Publicado: (2018) -
CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV
por: Ding, Ronghua, et al.
Publicado: (2021) -
An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites
por: Sun, Nan, et al.
Publicado: (2017)